TY - JOUR AU - Piver, M. S. AU - Baker, T. R. AU - Piedmonte, M. AU - Sandecki, A. M. PY - 1991 DA - 1991// TI - Epidemiology and etiology of ovarian cancer JO - Semin Oncol VL - 18 ID - Piver1991 ER - TY - JOUR AU - Neijt, J. P. AU - ten Bokkel Huinink, W. W. AU - van der Burg, M. E. AU - van Oosterom, A. T. AU - Willemse, P. H. AU - Vermorken, J. B. AU - van Lindert, A. C. AU - Heintz, A. P. AU - Aartsen, E. AU - van Lent, M. PY - 1991 DA - 1991// TI - Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer JO - Eur J Cancer VL - 27 UR - https://doi.org/10.1016/0277-5379(91)90011-2 DO - 10.1016/0277-5379(91)90011-2 ID - Neijt1991 ER - TY - JOUR AU - Angioli, R. AU - Palaia, I. AU - Damiani, P. AU - Montera, R. AU - Benedetti Panici, P. PY - 2006 DA - 2006// TI - [Up-date on cytoreductive surgery in the management of advanced ovarian cancer] JO - Minerva Ginecol VL - 58 ID - Angioli2006 ER - TY - JOUR AU - Markman, M. AU - Rothman, R. AU - Hakes, T. AU - Reichman, B. AU - Hoskins, W. AU - Rubin, S. AU - Jones, W. AU - Almadrones, L. AU - Lewis, J. L. PY - 1991 DA - 1991// TI - Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin JO - J Clin Oncol VL - 9 ID - Markman1991 ER - TY - JOUR AU - van der Burg, M. E. AU - Hoff, A. M. AU - van Lent, M. AU - Rodenburg, C. J. AU - van Putten, W. L. AU - Stoter, G. PY - 1991 DA - 1991// TI - Carboplatin and cyclophosphamide salvage therapy for ovarian cancer patients relapsing after cisplatin combination chemotherapy JO - Eur J Cancer VL - 27 UR - https://doi.org/10.1016/0277-5379(91)90507-A DO - 10.1016/0277-5379(91)90507-A ID - van der Burg1991 ER - TY - JOUR AU - Eisenhauer, E. A. AU - ten Bokkel Huinink, W. W. AU - Swenerton, K. D. AU - Gianni, L. AU - Myles, J. AU - van der Burg, M. E. AU - Kerr, I. AU - Vermorken, J. B. AU - Buser, K. AU - Colombo, N. PY - 1994 DA - 1994// TI - European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion JO - J Clin Oncol VL - 12 ID - Eisenhauer1994 ER - TY - JOUR AU - van der Burg, M. E. AU - van der Gaast, A. AU - Vergote, I. AU - Burger, C. W. AU - van Doorn, H. C. AU - de Wit, R. AU - Stoter, G. AU - Verweij, J. PY - 2005 DA - 2005// TI - What is the role of dose-dense therapy? JO - Int J Gynecol Cancer VL - 15 UR - https://doi.org/10.1111/j.1525-1438.2005.00432.x DO - 10.1111/j.1525-1438.2005.00432.x ID - van der Burg2005 ER - TY - JOUR AU - Vasey, P. A. PY - 2005 DA - 2005// TI - "Dose dense" chemotherapy in ovarian cancer JO - Int J Gynecol Cancer VL - 15 UR - https://doi.org/10.1111/j.1525-1438.2005.00438.x DO - 10.1111/j.1525-1438.2005.00438.x ID - Vasey2005 ER - TY - JOUR AU - Simon, R. AU - Norton, L. PY - 2006 DA - 2006// TI - The Norton-Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens JO - Nat Clin Pract Oncol VL - 3 UR - https://doi.org/10.1038/ncponc0560 DO - 10.1038/ncponc0560 ID - Simon2006 ER - TY - JOUR AU - Citron, M. L. AU - Berry, D. A. AU - Cirrincione, C. AU - Hudis, C. AU - Winer, E. P. AU - Gradishar, W. J. AU - Davidson, N. E. AU - Martino, S. AU - Livingston, R. AU - Ingle, J. N. PY - 2003 DA - 2003// TI - Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.09.081 DO - 10.1200/JCO.2003.09.081 ID - Citron2003 ER - TY - JOUR AU - Katsumata, N. AU - Yasuda, M. AU - Takahashi, F. AU - Isonishi, S. AU - Jobo, T. AU - Aoki, D. AU - Tsuda, H. AU - Sugiyama, T. AU - Kodama, S. AU - Kimura, E. PY - 2009 DA - 2009// TI - Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)61157-0 DO - 10.1016/S0140-6736(09)61157-0 ID - Katsumata2009 ER - TY - STD TI - Fujiwara K, Aotani E, Hamano T, Nagao S, Yoshikawa H, Sugiyama T, Kigawa J, Aoki D, Katsumata N, Takeuchi M, et al: A randomized Phase II/III trial of 3 weekly intraperitoneal versus intravenous carboplatin in combination with intravenous weekly dose-dense paclitaxel for newly diagnosed ovarian, fallopian tube and primary peritoneal cancer. Jpn J Clin Oncol. 41 (2): 278-282. ID - ref12 ER - TY - JOUR AU - Daga, H. AU - Isobe, T. AU - Miyazaki, M. AU - Fujitaka, K. AU - Kondo, K. AU - Kohno, N. PY - 2004 DA - 2004// TI - Investigating the relationship between serum thrombopoietin kinetics and the platelet-sparing effect: A clinical pharmacological evaluation of combined paclitaxel and carboplatin in patients with non-small cell lung cancer JO - Oncol Rep VL - 11 ID - Daga2004 ER - TY - BOOK AU - van Warmerdam, L. J. AU - Huizing, M. T. AU - Giaccone, G. AU - Postmus, P. E. AU - ten Bokkel Huinink, W. W. AU - van Zandwijk, N. AU - Koolen, M. G. AU - Helmerhorst, T. J. AU - van der Vijgh, W. J. AU - Veenhof, C. H. PY - 1997 DA - 1997// TI - Clinical pharmacology of carboplatin administered in combination with paclitaxel ID - van Warmerdam1997 ER - TY - JOUR AU - Ishikawa, H. AU - Fujiwara, K. AU - Suzuki, S. AU - Tanaka, Y. AU - Kohno, I. PY - 2002 DA - 2002// TI - Platelet-sparing effect of paclitaxel in heavily pretreated ovarian cancer patients JO - Int J Clin Oncol VL - 7 ID - Ishikawa2002 ER - TY - JOUR AU - Akerley, W. AU - Rathore, R. AU - Ready, N. AU - Leone, L. AU - Sikov, W. AU - Safran, H. AU - Kennedy, T. PY - 2002 DA - 2002// TI - A phase I study of a weekly schedule of paclitaxel and carboplatin in patients with advanced carcinoma JO - Cancer VL - 95 UR - https://doi.org/10.1002/cncr.10902 DO - 10.1002/cncr.10902 ID - Akerley2002 ER - TY - JOUR AU - Sehouli, J. AU - Stengel, D. AU - Elling, D. AU - Ortmann, O. AU - Blohmer, J. AU - Riess, H. AU - Lichtenegger, W. PY - 2002 DA - 2002// TI - First-line chemotherapy with weekly paclitaxel and carboplatin for advanced ovarian cancer: a phase I study JO - Gynecol Oncol VL - 85 UR - https://doi.org/10.1006/gyno.2002.6623 DO - 10.1006/gyno.2002.6623 ID - Sehouli2002 ER - TY - JOUR AU - Calvert, A. H. AU - Newell, D. R. AU - Gumbrell, L. A. AU - O'Reilly, S. AU - Burnell, M. AU - Boxall, F. E. AU - Siddik, Z. H. AU - Judson, I. R. AU - Gore, M. E. AU - Wiltshaw, E. PY - 1989 DA - 1989// TI - Carboplatin dosage: prospective evaluation of a simple formula based on renal function JO - J Clin Oncol VL - 7 ID - Calvert1989 ER - TY - JOUR AU - Swisher, E. M. AU - Mutch, D. G. AU - Rader, J. S. AU - Elbendary, A. AU - Herzog, T. J. PY - 1997 DA - 1997// TI - Topotecan in platinum- and paclitaxel-resistant ovarian cancer JO - Gynecol Oncol VL - 66 UR - https://doi.org/10.1006/gyno.1997.4787 DO - 10.1006/gyno.1997.4787 ID - Swisher1997 ER - TY - JOUR AU - Mutch, D. G. PY - 2002 DA - 2002// TI - Surgical management of ovarian cancer JO - Semin Oncol VL - 29 UR - https://doi.org/10.1053/sonc.2002.31589 DO - 10.1053/sonc.2002.31589 ID - Mutch2002 ER - TY - JOUR AU - Gordon, A. N. AU - Fleagle, J. T. AU - Guthrie, D. AU - Parkin, D. E. AU - Gore, M. E. AU - Lacave, A. J. PY - 2001 DA - 2001// TI - Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan JO - J Clin Oncol VL - 19 ID - Gordon2001 ER - TY - JOUR AU - de Jongh, F. E. AU - de Wit, R. AU - Verweij, J. AU - Sparreboom, A. AU - van den Bent, M. J. AU - Stoter, G. AU - van der Burg, M. E. PY - 2002 DA - 2002// TI - Dose-dense cisplatin/paclitaxel. a well-tolerated and highly effective chemotherapeutic regimen in patients with advanced ovarian cancer JO - Eur J Cancer VL - 38 UR - https://doi.org/10.1016/S0959-8049(02)00242-3 DO - 10.1016/S0959-8049(02)00242-3 ID - de Jongh2002 ER - TY - JOUR AU - Van der Burg, M. E. PY - 2004 DA - 2004// TI - Phase II study of weekly paclitaxel carboplatin in the treatment of progressive ovarian cancer JO - Journal of Clinical Oncology VL - 22 ID - Van der Burg2004 ER - TY - JOUR AU - Sharma, R. AU - Graham, J. AU - Mitchell, H. AU - Brooks, A. AU - Blagden, S. AU - Gabra, H. PY - 2009 DA - 2009// TI - Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer JO - Br J Cancer VL - 100 UR - https://doi.org/10.1038/sj.bjc.6604914 DO - 10.1038/sj.bjc.6604914 ID - Sharma2009 ER - TY - JOUR AU - Pertusini, E. AU - Ratajczak, J. AU - Majka, M. AU - Vaughn, D. AU - Ratajczak, M. Z. AU - Gewirtz, A. M. PY - 2001 DA - 2001// TI - Investigating the platelet-sparing mechanism of paclitaxel/carboplatin combination chemotherapy JO - Blood VL - 97 UR - https://doi.org/10.1182/blood.V97.3.638 DO - 10.1182/blood.V97.3.638 ID - Pertusini2001 ER - TY - JOUR AU - Parmar, M. K. AU - Ledermann, J. A. AU - Colombo, N. AU - du Bois, A. AU - Delaloye, J. F. AU - Kristensen, G. B. AU - Wheeler, S. AU - Swart, A. M. AU - Qian, W. AU - Torri, V. PY - 2003 DA - 2003// TI - Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial JO - Lancet VL - 361 UR - https://doi.org/10.1016/S0140-6736(03)13718-X DO - 10.1016/S0140-6736(03)13718-X ID - Parmar2003 ER - TY - CHAP AU - Stronach, E. A. AU - Rama, N. AU - Gabra, H. PY - 2008 DA - 2008// TI - Identification of functional modulators of platinum resistance using isogenically matched ovarian cancer cell line models BT - 2008 AACR Annual Meeting: 2008; San Diego: Proc of the 99th Annual Meeting of the American Association for Cancer Research ID - Stronach2008 ER - TY - JOUR AU - Linch, M. AU - Stavridi, F. AU - Hook, J. AU - Barbachano, Y. AU - Gore, M. AU - Kaye, S. B. PY - 2008 DA - 2008// TI - Experience in a UK cancer centre of weekly paclitaxel in the treatment of relapsed ovarian and primary peritoneal cancer JO - Gynecol Oncol VL - 109 UR - https://doi.org/10.1016/j.ygyno.2008.01.007 DO - 10.1016/j.ygyno.2008.01.007 ID - Linch2008 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/11/289/prepub UR - http://www.biomedcentral.com/1471-2407/11/289/prepub ID - ref29 ER -